MSC-derived exosomes promote chondrocyte proliferation and inhibit apoptosis by suppressing inflammation in osteoarthritis
Authors:
- 25 September 2025
- journal article
- Published by Elsevier in Tissue and Cell
- Vol. 98, 103157
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Osteoarthritis: pathogenic signaling pathways and therapeutic targetsSignal Transduction and Targeted Therapy, 2023
- Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKMCell Death & Disease, 2022
- Bone Marrow Mesenchymal Stromal Cell Treatment in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial InflammationStem Cells Translational Medicine, 2019
- Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical TrialStem Cells Translational Medicine, 2019
- MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritisCell Cycle, 2018
- MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivityBiomaterials, 2018
- Osteoarthritis: toward a comprehensive understanding of pathological mechanismBone Research, 2017
- OsteoarthritisThe Lancet, 2015
- Mesenchymal stem cells reduce pain but not degenerative changes in a mono-iodoacetate rat model of osteoarthritisJournal of Orthopaedic Research, 2014
- The NF-κB signalling pathway in osteoarthritisThe International Journal of Biochemistry & Cell Biology, 2013